Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript

VRTX earnings call for the period ending March 31, 2023.

Related Keywords

New Zealand ,Australia ,Canada ,Geoff Meacham ,Phil Nadeau ,Jessica Fye ,Charlie Wagner ,Reshma Kewalramani ,Jessica Fye Jpmorgan ,Andrew Tsai ,America Merrill Lynch ,Mohit Bansal ,Susie Lisa ,David Risinger ,Salveen Richter ,Colin Bristow ,Trikafta Kaftrio ,Michael Yee ,Phil Nadeau Cowen ,Andrew Tsai Jefferies ,Salveen Richter Goldman Sachs ,Stuart Arbuckle ,Goldman Sachs ,Exchange Commission ,Geoff Meacham Bank ,Company Analyst ,Vertex Pharmaceuticals ,Wells Fargo ,Innovation Center ,Vice President ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Lancet Respiratory ,New England Journal ,North America ,Cystic Fibrosis ,Gene Therapy ,Entrada Therapeutics ,Corporate Responsibility Report ,Fargo Securities ,Will Pickering ,Holy Grail ,Wells Fargo Securities ,